Takeda Pharmaceutical Company Limited (TAK)

NYQ – Real Time Price. Currency in USD

17.41

-0.07 (-0.43%)

Market open: Aug 12, 2026, 12:53 PM EDT

17.88

+0.40 (2.29%)

Previous after-hours: Aug 11, 2026, 7:55 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

29.90B

30.05B

29.52B

29.73B

Cost of goods sold

-13.73B

-13.95B

-13.43B

-12.76B

Gross Profit

16.17B

16.10B

16.97B

Operating expenses (excl. COGS)

-11.97B

-11.99B

-12.42B

-12.11B

Operating Income

4.20B

4.12B

3.68B

4.86B

Non-operating income, total

-5.13B

-2.94B

-3.36B

-2.03B

Pretax income

-930M

1.17B

321M

2.83B

Equity in earnings

-14M

-26M

45M

-64M

Taxes

-65M

-439M

633M

-429M

Non-controlling/minority interest

-2M

-1M

-900K

-155K

After tax other income/expense

Net income before discontinued operations

-1.01B

708M

998M

2.34B

Discontinued operations

Net income

-1.01B

708M

998M

2.34B

Dilution adjustment

Preferred dividends

Takeda Pharmaceutical Company Limited (TAK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Takeda Pharmaceutical Company Limited (TAK)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Takeda Pharmaceutical Company Limited (TAK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Takeda Pharmaceutical Company Limited (TAK)

Income Statement (Annual)

Income Statement (Annual)